PGE1 as Additive Anticoagulant in ECMO-Therapy

Clinical trial NCT02895373 · TERMINATED

Trial details

NCT number: NCT02895373
Sponsor: Thomas Staudinger
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Respiratory Distress Syndrome, Adult Extracorporeal Membrane Oxygenation

Start date: 2016-07-01
Primary completion: 2021-05-01
Enrollment: 50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.